Characteristic morphology of invasive micropapillary carcinoma of the breast: An immunohistochemical analysis

Japanese Journal of Clinical Oncology

Volumn 40, Issue 8, 2010, Pages 781-787

  Yamaguchi, Rin ^a,b   Tanaka, Maki ^c   Kondo, Keiko ^a   Yokoyama, Toshiro ^a   Kaneko, Yuko ^c   Yamaguchi, Miki ^c   Ogata, Yutaka ^a   Nakashima, Osamu ^b   Kage, Masayoshi ^b   Yano, Hirohisa ^b  

^a KURUME UNIVERSITY MEDICAL CENTER   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Social Insurance Kurume Daiichi Hospital   (Japan)

Author keywords

Breast; Cytoplasm; Immunohistochemistry; Invasive micropapillary carcinoma; p63

Indexed keywords

CYTOKERATIN; CYTOKERATIN 14; CYTOKERATIN 18; CYTOKERATIN 34BETAE12; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 8; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; INVOLUCRIN; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P63; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; STAINING;

BREAST NEOPLASMS; CARCINOMA, PAPILLARY; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN PRECURSORS; STAINING AND LABELING;

EID: 77955265955     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyq056     Document Type: Article

References (22)

1. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993;6:660-2.
2. Middleton LP, Tressera F, Sobel ME, Bryant BR, Alburquerque A, Grases P, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol 1999;12:499-504.
3. Zekioglu O, Erhan Y, Ciris M, Bayramoglu H, Ozdemir N. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 2004;44:18-23.
4. Kim MJ, Gong G, Joo HJ, Ahn SH, Ro JY. Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component. Arch Pathol Lab Med 2005;129:1277-82.
5. Tavassoli FA, Devilee P, editor. Tumours of the Breast and Female Genital Organs. Pathology and Genetics of Tumours of the Digestive System. World Health Organization Classification of Tumours. Lyon, France: IARC Press 2003.
6. Luna-More S, Gonzalez B, Acedo C, Rodrigo I, Luna C. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol Res Pract 1994;190:668-74.
7. Tsuda H, Sakamaki C, Fukutomi T, Hirohashi S. Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites. Br J Cancer 1997;75:1519-24.
8. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wülfing P, van Diest PJ, et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 2005;206:451-7.
9. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008;68:989-97.
10. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001;98:10869-74.
11. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, etal. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367-74.
12. Bratthauer GL, Saenger JS, Strauss BL. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation. Histopathology 2005;47:611-6.
13. Xu Z, Wang W, Deng CX, Man YG. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness. Int J Biol Sci 2009;5:82-96.
14. Tsuda H, Tani Y, Weisenberger J, Kitada S, Hasegawa T, Murata T, et al. Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features. Cancer Sci 2005;96:333-9.
15. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T. Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC); Pathology Section. Jpn J Clin Oncol 1998;28:486-91.
16. Narahashi T, Niki T, Wang T, Goto A, Matsubara D, Funata N, et al. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma. Histopathology 2006;49:349-57.
17. Rushing EJ, Olsen C, Man YG. Correlation of p63 immunoreactivity with tumor grade in meningiomas. Int J Surg Pathol 2008;16:38-42.
18. Dhillon PK, Barry M, Stampfer MJ, Perner S, Fiorentino M, Fornari A, et al. Aberrant cytoplasmic expression of p63 and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 2009;18:595-600.
19. Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, et al. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas. J Pathol 2002;198:100-9.
20. Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004;28:1506-12.
21. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008;216:141-50.
22. Marchio C, Iravani M, Natrajan R, Lambros MB, Savage K, Tamber N, et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J Pathol 2008;215:398-410.